Literature DB >> 19424875

Non-peptide arginine-vasopressin antagonists (vaptans) for the treatment of hyponatremia in neurocritical care: a new alternative?

Jeremy D Fields, Anish Bhardwaj.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19424875      PMCID： PMC7103236          DOI： 10.1007/s12028-009-9224-x

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN： 1541-6933            Impact factor:   3.210


× No keyword cloud information.
  18 in total

Review 1.  Neurological impact of vasopressin dysregulation and hyponatremia.

Authors:  Anish Bhardwaj
Journal:  Ann Neurol       Date:  2006-02       Impact factor: 10.422

Review 2.  Clinical practice. The syndrome of inappropriate antidiuresis.

Authors:  David H Ellison; Tomas Berl
Journal:  N Engl J Med       Date:  2007-05-17       Impact factor: 91.245

Review 3.  Non-peptide arginine-vasopressin antagonists: the vaptans.

Authors:  Guy Decaux; Alain Soupart; Gilbert Vassart
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321

4.  A novel role of vasopressin in the brain: modulation of activity-dependent water flux in the neocortex.

Authors:  H Niermann; M Amiry-Moghaddam; K Holthoff; O W Witte; O P Ottersen
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

5.  Cerebral correlates of hyponatremia.

Authors:  Barnett R Nathan
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

6.  Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit.

Authors:  Theresa Murphy; Rajat Dhar; Michael Diringer
Journal:  Neurocrit Care       Date:  2009-01-04       Impact factor: 3.210

Review 7.  The role of aquaporin-4 in cerebral water transport and edema.

Authors:  Orin Bloch; Geoffrey T Manley
Journal:  Neurosurg Focus       Date:  2007-05-15       Impact factor: 4.047

Review 8.  Therapeutic potential of vasopressin receptor antagonists.

Authors:  Farhan Ali; Maya Guglin; Peter Vaitkevicius; Jalal K Ghali
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Conivaptan for hyponatremia in the neurocritical care unit.

Authors:  Wendy L Wright; William H Asbury; Jane L Gilmore; Owen B Samuels
Journal:  Neurocrit Care       Date:  2008-11-12       Impact factor: 3.210

10.  Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial.

Authors:  James E Udelson; Cesare Orlandi; John Ouyang; Holly Krasa; Christopher A Zimmer; Geir Frivold; W Herbert Haught; Sheiba Meymandi; Cezar Macarie; Dimitar Raef; Patricia Wedge; Marvin A Konstam; Mihai Gheorghiade
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094
View more
  5 in total

1.  Conivaptan, a Selective Arginine Vasopressin V1a and V2 Receptor Antagonist Attenuates Global Cerebral Edema Following Experimental Cardiac Arrest via Perivascular Pool of Aquaporin-4.

Authors:  Shin Nakayama; Mahmood Amiry-Moghaddam; Ole Petter Ottersen; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2016-04       Impact factor: 3.210

2.  Arginine-vasopressin V1 but not V2 receptor antagonism modulates infarct volume, brain water content, and aquaporin-4 expression following experimental stroke.

Authors:  Xiaoqin Liu; Shin Nakayama; Mahmood Amiry-Moghaddam; Ole Petter Ottersen; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2010-02       Impact factor: 3.210

Review 3.  Review of Drug Repositioning Approaches and Resources.

Authors:  Hanqing Xue; Jie Li; Haozhe Xie; Yadong Wang
Journal:  Int J Biol Sci       Date:  2018-07-13       Impact factor: 6.580

Review 4.  Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work.

Authors:  Rajesh Kumar; Seetha Harilal; Sheeba Varghese Gupta; Jobin Jose; Della Grace Thomas Parambi; Md Sahab Uddin; Muhammad Ajmal Shah; Bijo Mathew
Journal:  Eur J Med Chem       Date:  2019-08-08       Impact factor: 6.514

Review 5.  Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases

Authors:  Gerdi Tuli; Daniele Tessaris; Silvia Einaudi; Luisa De Sanctis; Patrizia Matarazzo
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-05-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.